Speaker illustration

Doctor Veronika Vejtasova

Motol University Hospital, Prague (Czechia)

Member of:

European Society of Cardiology
EAPCI

Dr. Veronika Vejtasova has been working at the Department of Cardiology, Motol University Hospital, Prague (Czech Republic) since January 2020. The main field of her interest is echocardiography and hypertrophic cardiomyopathy. During her pregradual studies, she already started her scientific career in non-invasive assessment of cardiovascular system while stuidying in a special general medicine programme. The positive experience led her to postgraduate studies of Preventive Medicine at Charles University, Prague in 2022. The subject of her studies are prognostic factors in patients with hypertrophic cardiomyopathy, as presented in the moderated poster at ESC Congress 2022.

Do female patients with hypertrophic cardiomyopathy have a worse prognosis than male patients?

Event: ESC Congress 2022

Topic: Hypertrophic Cardiomyopathy

Session: Insights in hypertrophic cardiomyopathy and Chagas‘ disease

Thumbnail

This platform is supported by

logo Novo Nordisk